Contact tracing in acute hepatitis C: The source patient identification and group overlap therapy proof-of-concept pilot program
summary
“Our study provides early evidence that contact tracing in HCV may be possible. Not only was the program successful at notifying and testing potentially high-risk PWIDs of their exposure to HCV, it was successful at linking several previously unengaged PWIDs into HCV treatment and more broadly harm reduction services, such as clean needle distribution, available at the SSP” (p. 75).. Full citation:
Eckhardt B, Aponte-Melendez Y, Kapadia SN, Mateu-Gelabert P (2022). Contact tracing in acute hepatitis C: The source patient identification and group overlap therapy proof-of-concept pilot program
Clinical Liver Disease, 20 (2), 72-76. doi: 10.1002/cld.1242. PMCID: PMC9405500.